How a tumour mechanically transforms its healthy neighbouring cells into tumour cells

May 12 2015

A growing tumour exerts considerable ongoing abnormal pressure on the healthy neighbouring cells. The CNRS/UPMC/Institut Curie team directed by Emmanuel Farge, Inserm Research Director at Institut Curie, has just discovered that this force can induce tumour gene expression. The physical stress induced by tumour growth might even trigger the initial phases of malignant transformation in the adjacent tissues. This major discovery is published in the 11 May 2015 issue of Nature.

While a tumour is actively growing, it gradually induces an abnormal and permanent pressure on the healthy neighbouring cells. Could this stress transform compressed healthy cells into tumour cells and affect the development of the tumour? This is the novel approach adopted by the Mechanics and Genetics of Embryonic and Tumoral Development[1] team led Emmanuel Farge, Inserm Research Director.

First, using experimental models, the researchers measured the pressure exerted by the growth of a colon tumour on the adjacent tissues. In doing so, they demonstrated that this mechanical stress activates the beta-catenin signalling pathway in the healthy tissues adjacent to the tumour, leading to the activation of tumour genes. “Beta-catenin is well known to activate tumorigenesis in many cancers,” notes Emmanuel Farge.

The mechanics of cancer: propagation strategies

Using magnets and healthy tissues loaded with magnetic liposomes, the team then mimicked the mechanical forces induced by a tumour in the surrounding tissues, and observed the consequences. “After two weeks of such mechanical stress, we observe an increase in phosphorylation (i.e. activation) of beta-catenin, together with its translocation to the cell nucleus,” observe the scientists. Under the effect of the stress, the beta-catenin protein detaches from the cell membrane to enter the nucleus, where it then activates oncogenes that promote tumour growth.

After a month, overexpression of the c-Myc oncogene, a target for beta-catenin, is then detected, which causes uncontrolled division of healthy cells, as well as overexpression of the target gene Zeb-1, which is responsible for the loss of cell adhesion that leads to invasiveness and metastasis.

After 2-3 months, aberrant crypt foci form in the colon (enlargement of the crypts and alteration of their structure), which corresponds to the initial steps in malignant transformation. “Activation by mechanical stress of the beta-catenin signalling pathway in the healthy tissues surrounding the tumour indicates a new way for a tumour to spread,” says Emmanuel Farge. “It creates an amplificatory autoregulation loop, a chain reaction, a real ‘domino effect:’ malignant changes mechanically induced by the tumour in the genetically healthy neighbouring cells cause abnormal growth of these cells, which itself applies abnormal stress to the as yet non-malignant neighbouring cells, and so on, in  a process likely to considerably amplify tumour growth and spread.”

In addition, it might contribute to tumour heterogeneity: the tumorigenic processes triggered in the adjacent cells might generate tumour cells with characteristics that are distinct from those at the core of the tumour and different in their type of response to treatment. This method of proliferation might thus constitute a factor in resistance to therapeutic treatments. 

Everything is therefore not purely biochemical in the development of colon cancer. Abnormal mechanical stresses, activating tumour biomolecules, thus appear to be a potential new engine for tumour progression and invasion.

This discovery reveals that mechanical stresses caused by growth of the tumour are likely to modify the healthy cells adjacent to it, activating the malignant transformations that boost its development.

These data should therefore be incorporated into therapeutic approaches, since the complete elimination of tumours should include action on all mechanisms used by the tumour in order to grow.

Note

[1] “PhysicalChemistry Curie” Unit, CNRS/UPMC/Institut Curie Joint Research Unit 168


Back to release list of thematic

Know more

Researcher Contact

Emmanuel Farge
Inserm Research Director
UMR168 UNITE PHYSICO-CHIMIE CURIE (PCC)
efarge@curie.fr
 01 56 24 67 60

Sources

Mechanical induction of the tumourogenic β-cateninpathway by tumour growth pressure María Elena Fernández-Sánchez (1+), Sandrine Barbier (1+), Joanne Whitehead (1), Gaëlle Béalle (2), Aude Michel (2), Heldmuth Latorre-Ossa (3), Colette Rey (4), Laura Fouassier (4), Audrey Claperon (4), Laura Brullé (5), Elodie Girard (6), Nicolas Servant (6), Thomas Rio-Frio (7), Hélène Marie (8), Sylviane Lesieur (8), Chantal Housset (4), Jean-Luc Gennisson (3), Mickaël Tanter (3), Christine Ménager (2), Silvia Fre (9), Sylvie Robine (10), Emmanuel Farge(1).

1 CNRS UMR 168 Physicochimie Curie Mechanics and Genetics of Embryonic and Tumour Development INSERM, PSL Research University, Fondation Pierre-Gilles de Gennes, Institut Curie – Centre de Recherche
 2 UPMC Univ Paris 06, Sorbonne Universités, Laboratoire PHENIX Physico-chimie des Electrolytes et Nanosystèmes InterfaciauX, CNRS UMR 8234, F-75005, Paris, France
 3 Langevin Institut – Waves and Images ESPCI ParisTech, PSL Research University, CNRS UMR7587, Inserm U979
 4 Sorbonne Universités, UPMC Univ Paris 06 & INSERM, UMR-S 938, CDR Saint-Antoine, F-75012, Paris, France
 5 CNRS UMR3666 / INSERM U1143 Endocytic Trafficking and Therapeutic Delivery Institut Curie – Centre de Recherche
 6 Bioinformatic platform, U900 – Institut Curie–Mines-ParisTech 7 Next-generation sequencing platform, Institut Curie
 8 CNRS UMR 8612, Laboratoire Physico-Chimie des Systèmes Polyphasés Institut Galien Paris-Sud, LabEx LERMIT, Faculté de Pharmacie – Université Paris-Sud
 9 CNRS UMR 3215 / Inserm U934 Unité de Génétique et Biologie du Développement Notch signaling in stem cells and tumors Institut Curie – Centre de Recherche
10 CNRS UMR144 Compartimentation et dynamique cellulaires, Morphogenesis and Cell Signalling Institut Curie – Centre de Recherche

Nature, 11 mars 2015

Press Contact

Institut Curie
Catherine Goupillon-Senghor
01 56 24 55 23
service.presse@curie.fr
Inserm
presse@inserm.fr

^ Top of page
View Edit Create here